ALLIOSPHARMA resources focused on leads selection, state-of-the-art development and positioning activities
Pragmatic and balanced portfolio, with a good risk/reward ratio
Selection of precise biological targets with significant unmet needs, in serious conditions with high prevalence and big public health concern.
Pragmatic, multitechnology-driven, approach, without the constraints of one sole technologic platform and research center: multiple collaborations with high tech academic labs and private research companies, worldwide.
